ConforMIS
Develops and manufactures patient-specific knee and hip implants using proprietary iFit Image-to-Implant platform and 3D printing, reducing surgical complexity and improving fit.
- CEO / Founder
- Mark Augusti
- Team Size
- 501-1000
- Stage
- Acquired
- Total Funding
- $135M
- Latest Round
- IPO
- Key Investors
- Oxford Finance; Synchrony
Technology & Products
Key Products
iTotal knee replacement system; iTotal hip replacement system; Imprint knee replacement system; Surgery-in-a-Box delivery system
Technological Advantage
ConforMIS's proprietary iFit platform and additive manufacturing process enable mass customization of implants, protected by a strong patent portfolio. The company's ability to produce patient-specific implants at scale is a key differentiator, though the technology is replicable by well-funded competitors.
Differentiation
Value Proposition
Provides personalized implants that match each patient's anatomy, potentially reducing revision rates and improving patient outcomes, while streamlining surgical workflow with single-use instruments.
How They Differentiate
Unlike traditional implant manufacturers offering standard sizes, ConforMIS provides fully personalized implants and instruments based on each patient's CT scan, potentially improving fit and outcomes.
Market & Competition
Target Customers
Hospitals, surgeons, orthopedic care providers
Industry Verticals
Medical devices; Orthopedics
Competitors
Zimmer Biomet; Stryker; Smith & Nephew
Growth & Milestones
Growth Metrics
Achieved 100,000 implant milestone in 2019; revenue in Q2 2020 was $19.47M.
Major Milestones
Founded in 2004; IPO on NASDAQ in 2015; Acquired by restor3d in 2023
Notable Customers
Hospitals and surgeons using ConforMIS implants